Recall Z-1595-2021

Roche Diagnostics Operations, Inc. · initiated April 7, 2021

Class II Open, Classified

Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature

Product

Elecsys Troponin I STAT Immunoassay: Catalog# 05094798160 - Product Usage: intended to aid in the diagnosis of myocardial infarction.

Codes / lots: UDI: 04015630939381

Reason for recall

Recall reason is possible sporadic false negative conventional troponin results. Roche has confirmed an issue with running Elecsys Troponin I/Troponin I STAT and Elecsys proBNP II/proBNP II STAT on the cobas e 601 and 602 modules. When the proBNP II analyte is measured immediately before the Troponin I analyte on the same module, a decreased recovery on Troponin I was observed.

FDA-determined cause: Device Design

Action taken

On 04/07/2021, Roche issued Urgent Medical Device Correction via fax notifying customers that Roche has confirmed an issue with running Elecsys Troponin I/Troponin I STAT and Elecsys proBNP II/ proBNP II STAT on the cobas e 601 and 602 modules. When the proBNP II analyte was measured immediately before the Troponin I analyte on the same module, a decreased recovery of Troponin I was observed.

Details

Recall number
Z-1595-2021
Initiated
April 7, 2021
Product code
MMI – Immunoassay Method, Troponin Subunit
Quantity
10, 489 kits
Distribution
US Nationwide distribution in the states of AL, AZ, CA, CT, FL, GA, ID, IL, IN,KS, KY, MD, ME, MO, NC, NE, NJ, NM, NY, OH, OK, SC, SD, TN, TX, VA, WA, WY.
Recalling firm
Roche Diagnostics Operations, Inc., Indianapolis, IN

Official FDA recall record

Other products in the same recall event

RecallProductInitiated
Z-1596-2021 Class IIElecsys Troponin I Immunoassay: Catalog# 05094810160 - Product Usage: intended to aid in…Recall reason is possible sporadic false negative conventional troponin results. Roche has confirmed an… 04/07/2021Open, Classified